大咖对话第3期（音频）：Suneil Hosmane博士-AI数字病理学的对话

Episode 3 with Dr. Suneil Hosmane - Dialogues on AI Digital Pathology.

Listen to our guest, Dr. Suneil Hosmane (Executive Vice President and Global Head of Diagnostics at GENFIT), as he speaks about the role of AI digital pathology, the latest NIS4 blood-based diagnostic test by Genfit and how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts in NASH clinical trials today that could ultimately transform the NASH clinical care pathway.

Introduction of
Dr. Suneil Hosmane

Dr. Suneil Hosmane,Ph.D.Executive Vice President and Global Head of Diagnostics at GENFIT

Suneil Hosmane has served as Head of Global Diagnostics at GENFIT since October 2019.  Prior to that Suneil served as the Executive Vice President of Strategic Development at GENFIT Corp., which he joined at the end of 2017. He has had a leadership role on multiple strategic initiatives that span across GENFIT’s therapeutic and diagnostic programs. Prior to joining GENFIT, he held positions of increasing responsibility at Becton Dickinson Diagnostics, Intercept Pharmaceuticals, and EchoSens. 

▲ A picture of Suneil Hosmane, Ph.D.

Suneil holds a Ph.D. in Biomedical Engineering from the Johns Hopkins University School of Medicine and a BSc/MSc in Electrical Engineering from the University of Illinois at Urbana-Champaign.

往期

关于我们

新加坡医疗科技公司HistoIndex，是杭州筹图科技有限公司的母公司，我们利用人工智能的图像分析技术和全球独创的无染色成像技术相结合应用于疾病进展的评价，特别是NASH新药开发的病理评价中。目前该技术平台已经在NASH临床前的多个动物模型和多个II，III期临床试验上做了深入研究和算法验证，已经参与完成近四十家国际国内知名药企、大型CRO公司和科研机构主办的相关试验。

想了解更多？
那就赶紧来关注我们

长按二维码 关注我们

有问题请联系我们
   热线电话：
 4009-6565-83